MINNETONKA, Minn. / Jun 07, 2023 / Business Wire / UnitedHealth Group (NYSE: UNH) announced an increase to its dividend and provided an update on its 2023 annual shareholder meeting.
The Board of Directors authorized a 14% increase to its quarterly cash dividend. A cash dividend of $1.88 per share, will be paid on June 27, 2023, to all shareholders of record of UNH common stock as of the close of business June 19, 2023. This dividend represents an increase over the quarterly dividend of $1.65 per share the Company has paid since the second quarter of 2022.
At the annual meeting, shareholders:
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow @UnitedHealthGrp on Twitter.
Last Trade: | US$500.70 |
Daily Change: | 11.45 2.34 |
Daily Volume: | 9,403,075 |
Market Cap: | US$460.780B |
October 15, 2024 July 16, 2024 May 23, 2024 September 12, 2023 August 17, 2023 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREAstria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB